SQ109
| Title | Journal |
|---|---|
| Head-to-head prenyl tranferases: anti-infective drug targets. | Journal of medicinal chemistry 20120510 |
| SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro. | The Journal of antimicrobial chemotherapy 20120501 |
| Tuberculosis: the drug development pipeline at a glance. | European journal of medicinal chemistry 20120501 |
| Synthesis and in vitro antimycobacterial activity of compounds derived from (R)- and (S)-2-amino-1-butanol - The crucial role of the configuration. | European journal of medicinal chemistry 20120201 |
| Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide. | PloS one 20120101 |
| Design, synthesis, and biological evaluation of novel fluorinated ethanolamines. | Chemistry (Weinheim an der Bergstrasse, Germany) 20111223 |
| Novel linear diamine disubstituted polycyclic 'cage' derivatives as potential antimycobacterial candidates. | Chemical biology & drug design 20111201 |
| The many faces of the adamantyl group in drug design. | European journal of medicinal chemistry 20110601 |
| [Present and future in the use of anti-tubercular drugs]. | Pneumologia (Bucharest, Romania) 20110101 |
| Drugs in development for tuberculosis. | Drugs 20101203 |
| In vitro interactions between new antitubercular drug candidates SQ109 and TMC207. | Antimicrobial agents and chemotherapy 20100701 |
| Current development and future prospects in chemotherapy of tuberculosis. | Respirology (Carlton, Vic.) 20100701 |
| Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates. | European journal of medicinal chemistry 20100501 |
| Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents. | European journal of medicinal chemistry 20091101 |
| Synthesis and evaluation of carbamate prodrugs of SQ109 as antituberculosis agents. | Bioorganic & medicinal chemistry letters 20090515 |
| SQ109. | Tuberculosis (Edinburgh, Scotland) 20080301 |
| New anti-tuberculosis drugs with novel mechanisms of action. | Current medicinal chemistry 20080101 |
| Advances in the treatment of tuberculosis. | Clinical pharmacology and therapeutics 20071101 |
| New tuberculosis therapeutics: a growing pipeline. | The Journal of infectious diseases 20070815 |
| Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs. | Antimicrobial agents and chemotherapy 20070401 |
| Novel agents in the management of Mycobacterium tuberculosis disease. | Current medicinal chemistry 20070101 |
| Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro. | The Journal of antimicrobial chemotherapy 20060801 |
| Interspecies pharmacokinetics and in vitro metabolism of SQ109. | British journal of pharmacology 20060301 |
| Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N'-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv. | The Journal of pharmacology and experimental therapeutics 20051101 |